258 related articles for article (PubMed ID: 30806314)
1. Pharmacophores Modeling in Terms of Prediction of Theoretical Physicochemical Properties and Verification by EXPERIMENTAL correlations of Carbacylamidophosphates (CAPh) and Sulfanylamidophosphates (SAPh) Tested as New Carbonic Anhydrase Inhibitors.
Amirkhanov V; Rauf A; Hadda TB; Ovchynnikov V; Trush V; Saleem M; Raza M; Rehman T; Zgou H; Shaheen U; Farghaly TA
Mini Rev Med Chem; 2019; 19(12):1015-1027. PubMed ID: 30806314
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrazones as new class of carbonic anhydrase inhibitors: Synthesis, kinetics, and ligand docking studies.
Iqbal S; Saleem M; Azim MK; Taha M; Salar U; Khan KM; Perveen S; Choudhary MI
Bioorg Chem; 2017 Jun; 72():89-101. PubMed ID: 28390994
[TBL] [Abstract][Full Text] [Related]
3. Utilization of the common functional groups in bioactive molecules: Exploring dual inhibitory potential and computational analysis of keto esters against α-glucosidase and carbonic anhydrase-II enzymes.
Khan I; Khan A; Halim SA; Khan M; Zaib S; Al-Yahyaei BEM; Al-Harrasi A; Ibrar A
Int J Biol Macromol; 2021 Jan; 167():233-244. PubMed ID: 33249154
[TBL] [Abstract][Full Text] [Related]
4. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
[TBL] [Abstract][Full Text] [Related]
6. Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship.
Gao R; Liao S; Zhang C; Zhu W; Wang L; Huang J; Zhao Z; Li H; Qian X; Xu Y
Eur J Med Chem; 2013 Apr; 62():597-604. PubMed ID: 23429054
[TBL] [Abstract][Full Text] [Related]
7. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
[TBL] [Abstract][Full Text] [Related]
9. New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.
Zaib S; Saeed A; Stolte K; Flörke U; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():140-50. PubMed ID: 24681391
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationship for Sulfonamide Inhibition of Helicobacter pylori α-Carbonic Anhydrase.
Modak JK; Liu YC; Supuran CT; Roujeinikova A
J Med Chem; 2016 Dec; 59(24):11098-11109. PubMed ID: 28002963
[TBL] [Abstract][Full Text] [Related]
11. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
[TBL] [Abstract][Full Text] [Related]
12. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, carbonic anhydrase inhibition, anticancer activity, and molecular docking studies of 1,3,4-oxadiazole derivatives.
Vanjare BD; Choi NG; Eom YS; Raza H; Hassan M; Lee KH; Kim SJ
Mol Divers; 2023 Feb; 27(1):193-208. PubMed ID: 35344136
[TBL] [Abstract][Full Text] [Related]
14. Bovine carbonic anhydrase (bCA) inhibitors: Synthesis, molecular docking and theoretical studies of bisoxadiazole-substituted sulfonamide derivatives.
Eybek A; Kaya MO; Güleç Ö; Demirci T; Musatat AB; Özdemir O; Öner MNK; Kaya Y; Arslan M
Int J Biol Macromol; 2024 May; 267(Pt 1):131489. PubMed ID: 38608980
[TBL] [Abstract][Full Text] [Related]
15. Spirobisnaphthalenes effectively inhibit carbonic anhydrase.
Gocer H; Aslan A; Gülçin İ; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(3):503-7. PubMed ID: 26018418
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
17. Novel 2-indolinones containing a sulfonamide moiety as selective inhibitors of candida β-carbonic anhydrase enzyme.
Akdemir A; Angeli A; Göktaş F; Eraslan Elma P; Karalı N; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):528-531. PubMed ID: 30724625
[TBL] [Abstract][Full Text] [Related]
18. 2-Amino-3-cyanopyridine derivatives as carbonic anhydrase inhibitors.
Ayvaz S; Çankaya M; Atasever A; Altuntas A
J Enzyme Inhib Med Chem; 2013 Apr; 28(2):305-10. PubMed ID: 22141460
[TBL] [Abstract][Full Text] [Related]
19. Exploring benzoxaborole derivatives as carbonic anhydrase inhibitors: a structural and computational analysis reveals their conformational variability as a tool to increase enzyme selectivity.
Langella E; Alterio V; D'Ambrosio K; Cadoni R; Winum JY; Supuran CT; Monti SM; De Simone G; Di Fiore A
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1498-1505. PubMed ID: 31423863
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors with dual-tail moieties to match the hydrophobic and hydrophilic halves of the carbonic anhydrase active site.
Tanpure RP; Ren B; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2015 Feb; 58(3):1494-501. PubMed ID: 25581127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
